Boundless Bio, Inc.
BOLD
$1.15
-$0.02-1.71%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -6.48% | -7.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.57% | -11.21% | |||
| Operating Income | 7.57% | 11.21% | |||
| Income Before Tax | 7.16% | 11.46% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7.16% | 11.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7.16% | 11.46% | |||
| EBIT | 7.57% | 11.21% | |||
| EBITDA | 7.70% | 11.38% | |||
| EPS Basic | 7.23% | 11.58% | |||
| Normalized Basic EPS | 7.23% | 11.57% | |||
| EPS Diluted | 7.23% | 11.58% | |||
| Normalized Diluted EPS | 7.23% | 11.57% | |||
| Average Basic Shares Outstanding | 0.06% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.06% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||